(Q39218868)

10 September 2017

title

Hepatitis C virus-infected patients report communication problems with physicians (English)

1 reference

10 September 2017

0 references

1 reference

1 reference

Susan Zickmund

1

1 reference

10 September 2017

Stephen L Hillis

2

1 reference

10 September 2017

Mitchell J Barnett

3

1 reference

10 September 2017

Laura Ippolito

4

1 reference

10 September 2017

Douglas R LaBrecque

5

1 reference

10 September 2017

language of work or name

English

0 references

publication date

1 April 2004

1 reference

10 September 2017

1 reference

10 September 2017

volume

39

1 reference

10 September 2017

issue

4

1 reference

10 September 2017

page(s)

999-1007

1 reference

Is patient satisfaction a unidimensional construct? Factor analysis of the Munich Patient Satisfaction Scale (MPSS-24).

10 September 2017

cites work

1 reference

The meaning and use of the area under a receiver operating characteristic (ROC) curve

21 January 2018

1 reference

The effects of patient communication skills training on compliance

21 January 2018

1 reference

7 January 2021

Doctor-patient communication. Clinical implications of social scientific research

1 reference

7 January 2021

Difficult patient encounters in the ambulatory clinic: clinical predictors and outcomes.

1 reference

7 January 2021

The 'difficult patient' as perceived by family physicians

1 reference

7 January 2021

Psychiatric symptoms in disliked medical patients

1 reference

7 January 2021

Comorbidities and quality of life in patients with interferon-refractory chronic hepatitis C.

1 reference

7 January 2021

"They treated me like a leper". Stigmatization and the quality of life of patients with hepatitis C.

1 reference

7 January 2021

Psychiatric disorders among veterans with hepatitis C infection

1 reference

7 January 2021

Emotional state, coping styles, and somatic variables in patients with chronic hepatitis C

1 reference

7 January 2021

Estimating future hepatitis C morbidity, mortality, and costs in the United States

1 reference

7 January 2021

Increase in alcohol related deaths: is hepatitis C a factor?

1 reference

7 January 2021

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

1 reference

7 January 2021

Adherence to combination therapy enhances sustained response in genotype-1-infected patients with chronic hepatitis C.

1 reference

7 January 2021

Compliance with therapy in patients with chronic hepatitis C: associations with psychiatric symptoms, interpersonal problems, and mode of acquisition.

1 reference

7 January 2021

The hospital anxiety and depression scale

1 reference

7 January 2021

The Sickness Impact Profile: Development and Final Revision of a Health Status Measure

1 reference

7 January 2021

The Measurement of Observer Agreement for Categorical Data

1 reference

7 January 2021

Regression modelling strategies for improved prognostic prediction

1 reference

7 January 2021

On the relationship between the efficiency and the quality of the consultation. A validity study

1 reference

7 January 2021

Patients' ratings of outpatient visits in different practice settings. Results from the Medical Outcomes Study

1 reference

7 January 2021

Racial and ethnic disparities in perceptions of physician style and trust.

1 reference

7 January 2021

Management of hepatitis C patients by primary care physicians in the USA: results of a national survey

1 reference

7 January 2021

Barriers to social support for persons living with HIV/AIDS

1 reference

7 January 2021

Stigmatisation of people with mental illnesses

1 reference

7 January 2021

Epilepsy in Pakistan: stigma and psychosocial problems. A population-based epidemiologic study

1 reference

7 January 2021

Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group

1 reference

7 January 2021

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

1 reference

7 January 2021

Peginterferon alfa-2a in patients with chronic hepatitis C.

1 reference

7 January 2021

Peginterferon alfa-2a in patients with chronic hepatitis C and cirrhosis

1 reference

7 January 2021

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.20132

1 reference

release_n7veyu7jlvdz7pf2goj2cj7mvm

10 September 2017

Fatcat ID

0 references

1 reference